Michael I Koukourakis1, Christos Kakouratos1, Dimitra Kalamida1, Zoi Bampali1, Sophia Mavropoulou2, Efthimios Sivridis3, Alexandra Giatromanolaki3. 1. a Department of Radiotherapy/Oncology , Democritus University of Thrace, and University General Hospital of Alexandroupolis , Alexandroupolis , Greece ; 2. c Department of Pathology , Xanthi General Hospital , Xanthi , Greece. 3. b Department of Pathology , Democritus University of Thrace, and University General Hospital of Alexandroupolis , Alexandroupolis , Greece ;
Abstract
PURPOSE: To assess whether anaerobic metabolism, proliferation activity and stem cell content are linked with radioresistance in bladder cancer. MATERIALS AND METHODS: Tissue sections from 66 patients with invasive transitional cell bladder cancer treated with hypofractionated accelerated radiotherapy, was immunohistochemically analyzed for the Hypoxia-Inducible Factor 1α (HIF1α) and the anaerobic glycolysis enzyme lactate dehydrogenase 5 (LDH5). Proliferation index (Ki-67) and stem-cell marker (cluster of differentiation CD44, aldehyde dehydrogenase ALDH1) expression was also examined. RESULTS: Both HIF1α and LDH5 expression were linked with high CD44 stem cell population (p = 0.001 and 0.05, respectively), while high Ki-67 proliferation index was linked with nuclear LDH5 expression (p = 0.03) and high histological grade (p = 0.02). A strong significant association of HIF1α (p = 0.0009) and of LDH5 (p < 0.0001) with poor local relapse free survival (LRFS) was noted, which was also confirmed in multivariate analysis. A significant association with overall survival was also noted. Silencing of lactate dehydrogenase LDHA gene in the human RT112 bladder cancer cell line, or exposure to oxamate (LDH activity inhibitor), resulted in strong radio-sensitization. CONCLUSIONS: HIF1α and LDH5 are markers of poor outcome in patients with bladder cancer treated with radiotherapy. Blockage of anaerobic metabolism may prove of importance in clinical radiotherapy.
PURPOSE: To assess whether anaerobic metabolism, proliferation activity and stem cell content are linked with radioresistance in bladder cancer. MATERIALS AND METHODS: Tissue sections from 66 patients with invasive transitional cell bladder cancer treated with hypofractionated accelerated radiotherapy, was immunohistochemically analyzed for the Hypoxia-Inducible Factor 1α (HIF1α) and the anaerobic glycolysis enzyme lactate dehydrogenase 5 (LDH5). Proliferation index (Ki-67) and stem-cell marker (cluster of differentiation CD44, aldehyde dehydrogenase ALDH1) expression was also examined. RESULTS: Both HIF1α and LDH5 expression were linked with high CD44 stem cell population (p = 0.001 and 0.05, respectively), while high Ki-67 proliferation index was linked with nuclear LDH5 expression (p = 0.03) and high histological grade (p = 0.02). A strong significant association of HIF1α (p = 0.0009) and of LDH5 (p < 0.0001) with poor local relapse free survival (LRFS) was noted, which was also confirmed in multivariate analysis. A significant association with overall survival was also noted. Silencing of lactate dehydrogenase LDHA gene in the human RT112 bladder cancer cell line, or exposure to oxamate (LDH activity inhibitor), resulted in strong radio-sensitization. CONCLUSIONS: HIF1α and LDH5 are markers of poor outcome in patients with bladder cancer treated with radiotherapy. Blockage of anaerobic metabolism may prove of importance in clinical radiotherapy.
Authors: Nzinga Mack; Elizabeth A Mazzio; David Bauer; Hernan Flores-Rozas; Karam F A Soliman Journal: Anticancer Res Date: 2017-03 Impact factor: 2.480
Authors: Masahiro Shindo; Masatomo Maeda; Ko Myat; Mayuresh M Mane; Ivan J Cohen; Kiranmayi Vemuri; Avi S Albeg; Inna Serganova; Ronald Blasberg Journal: Cancers (Basel) Date: 2022-05-06 Impact factor: 6.575
Authors: Chang Dong Yeo; Nahyeon Kang; Su Yeon Choi; Bit Na Kim; Chan Kwon Park; Jin Woo Kim; Young Kyoon Kim; Seung Joon Kim Journal: Korean J Intern Med Date: 2017-06-30 Impact factor: 2.884
Authors: Avgi Tsolou; Maria Liousia; Dimitra Kalamida; Stamatia Pouliliou; Alexandra Giatromanolaki; Michael Koukourakis Journal: Cancer Biol Med Date: 2017-08 Impact factor: 4.248